Data for NVL-655 in Advanced ALK+ NSCLC and Solid Tumors from the ALKOVE-1 Trial
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss data for NVL-655 in ALK-positive NSCLC and other ALK-positive solid tumors.
Related Articles
Evolving Paradigms In Advanced Ovarian Cancer Care
Navigate the evolving paradigms in advanced ovarian cancer care. Delve into the latest treatments and methodologies improving patient outcomes.
FDA Accepts BLA for Belantamab Mafodotin–Based Combos in R/R Myeloma
The FDA accepted a BLA for 2 belantamab mafodotin–based combinations in relapsed/refractory multiple myeloma.
FDA Approves HER2 Test as Companion Diagnostic for Zanidatamab in Biliary Tract Cancer
The FDA approved the PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test as a companion diagnostic to assess HER2+ status in patients with BTC.
ASH Annual Meeting Abstracts
Late-breaking abstracts feature substantive, novel, and groundbreaking data that were not available by the general abstract submission deadline and would otherwise not be presented at…
Ane Gerda Eriksson (@agerikssonmd.bsky.social)
👩🏼⚕️🇳🇴🏥Gyn Oncologist at The Norwegian Radium Hospital, Oslo University Hospital ESGO council @oncoalert faculty
Pharmacological blockade of a pioneer transcription factor
Abstract. Cancers frequently co-opt lineage-specific transcription factors (TFs) utilized in normal development to sustain proliferation. However, the effects of these TFs on tumor development depend…
Program
Program details for the 13th AACR-JCA Joint Conference: From Cancer Discovery Science to Therapeutic Innovation
Dual Inhibition of SYK and EGFR Overcomes Chemoresistance by Inhibiting CDC6 and Blocking DNA Replication
SYK and EGFR coinhibition exerts synergistic anticancer effects in chemoresistant ovarian cancer, providing a strategy to treat chemotherapy-resistant ovarian cancers using clinically available agents by…
Marching through a testicular cancer diagnosis
Grayson Niemi juggled chemo treatments for testicular cancer and practice sessions for joining Ohio State’s marching band. He made the band and also to the…
